Gemfibrozil, a lipid-lowering drug, induces suppressor of cytokine signaling 3 in glial cells: implications for neurodegenerative disorders

Gemfibrozil, a lipid-lowering drug, induces suppressor of cytokine signaling 3 in glial cells: implications for neurodegenerative disorders

Item
http://www.wikidata.org/entity/Q36137520
Redox control of microglial function: molecular mechanisms and functional significanceSodium Benzoate, a Metabolite of Cinnamon and a Food Additive, Upregulates Ciliary Neurotrophic Factor in Astrocytes and Oligodendrocytes.Gemfibrozil, a lipid-lowering drug, increases myelin genes in human oligodendrocytes via peroxisome proliferator-activated receptor-β.Gemfibrozil and fenofibrate, Food and Drug Administration-approved lipid-lowering drugs, up-regulate tripeptidyl-peptidase 1 in brain cells via peroxisome proliferator-activated receptor α: implications for late infantile Batten disease therapy.Sodium phenylbutyrate enhances astrocytic neurotrophin synthesis via protein kinase C (PKC)-mediated activation of cAMP-response element-binding protein (CREB): implications for Alzheimer disease therapyPPARα in lysosomal biogenesis: A perspective.Up-regulation of ciliary neurotrophic factor in astrocytes by aspirin: implications for remyelination in multiple sclerosis.Castration induces Parkinson disease pathologies in young male mice via inducible nitric-oxide synthaseRegulation of neurotrophin receptor (Trk) signaling: suppressor of cytokine signaling 2 (SOCS2) is a new player.Up-regulation of neurotrophic factors by cinnamon and its metabolite sodium benzoate: therapeutic implications for neurodegenerative disorders.Methylation and microRNA-mediated epigenetic regulation of SOCS3.Cinnamon Converts Poor Learning Mice to Good Learners: Implications for Memory Improvement.Gemfibrozil, food and drug administration-approved lipid-lowering drug, increases longevity in mouse model of late infantile neuronal ceroid lipofuscinosis.Upregulation of suppressor of cytokine signaling 3 in microglia by cinnamic acid.The Role of KLF in Alzheimer's DiseaseTesting the PPAR hypothesis of tobacco use disorder in humans: A randomized trial of the impact of gemfibrozil (a partial PPARα agonist) in smokers
P2860

Gemfibrozil, a lipid-lowering drug, induces suppressor of cytokine signaling 3 in glial cells: implications for neurodegenerative disorders

Item
http://www.wikidata.org/entity/Q36137520
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Gemfibrozil, a lipid-lowering ...... or neurodegenerative disorders
@ast
Gemfibrozil, a lipid-lowering ...... or neurodegenerative disorders
@en
type
label
Gemfibrozil, a lipid-lowering ...... or neurodegenerative disorders
@ast
Gemfibrozil, a lipid-lowering ...... or neurodegenerative disorders
@en
prefLabel
Gemfibrozil, a lipid-lowering ...... or neurodegenerative disorders
@ast
Gemfibrozil, a lipid-lowering ...... or neurodegenerative disorders
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P698
P921
P932
P356
P1433
P1476
Gemfibrozil, a lipid-lowering ...... or neurodegenerative disorders
@en
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P698
P921
P932